摘要
A novel coronavirus, later named SARS-CoV-2, was first reported in China in December 2019 and subsequently widely identified in the United States, Japan, South Korea, France, India, and other countries. The disease caused by SARS-CoV-2 infection was called COVID-19. The high fatality and morbidity rates of COVID-19 make it the third largest global epidemic in this century. However, there are currently no approved antiviral drugs for the COVID-19 treatment. Recently, two old antimalarial drugs, hydroxychloroquine and chloroquine, have been found to exert anti-SARS-CoV-2 effects both in vitro and in vivo. Preliminary clinical evidence suggests these drugs may have an effect on the treatment of COVID-19. Herein, we review the pharmacokinetics characteristics and antiviral effects of these drugs, in addition to their side effects and clinical evidence of their use for the COVID-19 treatment.
| 源语言 | 英语 |
|---|---|
| 页(从-至) | 765-772 |
| 页数 | 8 |
| 期刊 | Archives of Pharmacal Research |
| 卷 | 43 |
| 期 | 8 |
| DOI | |
| 出版状态 | 已出版 - 8月 2020 |
基金资助
This work was supported by grants from the National Natural Science Foundation of China (Grant Nos. 81822016 and 81771382) to Zhentao Zhang.
关键词
- Hydroxychloroquine
- Chloroquine
- COVID-19
- SARS-CoV-2
- Treatment
收录
- SCIE
- Scopus
学术指纹
探究 'Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19' 的科研主题。它们共同构成独一无二的学术指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver